Trulieve Cannabis Corp. (TCNNF) director receives 23,438 RSU grant

(Neutral)

Form Type

Rhea-AI Filing Summary

Healy Peter reported acquisition or exercise transactions in this Form 4 filing.

Trulieve Cannabis Corp. director Peter Healy reported an equity compensation grant in the form of restricted stock units (RSUs) covering 23,438 subordinate voting shares. The award was recorded at a price of $0.00 per unit, reflecting a grant rather than a market purchase. Following this grant, Healy is shown as holding 72,673 subordinate voting shares. Each RSU represents a contingent right to receive one Trulieve subordinate voting share and will vest on the earliest of the end of Healy’s board service, a change of control of Trulieve, or December 1, 2032.

Insider Trade Summary

Net Buyer: 23,438 shares

Net Buy 1 txn

Insider Healy Peter

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Subordinate Voting Shares	23,438	$0.00	$0.00

Holdings After Transaction: Subordinate Voting Shares — 72,673 shares (Direct)

Footnotes (1)

F1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. The RSUs will vest on the earliest of (i) the end of the reporting person's service on the board of directors of Trulieve, (ii) a change of control of Trulieve, or (iii) December 1, 2032.

FAQ

What insider transaction did Peter Healy report at Trulieve Cannabis Corp. (TCNNF)?

Peter Healy reported receiving a grant of 23,438 restricted stock units, each tied to one Trulieve subordinate voting share. The units were granted at $0.00 per share as equity compensation, not an open-market purchase, and are subject to future vesting conditions.

How many Trulieve Cannabis Corp. shares does Peter Healy hold after this Form 4?

After the reported grant, Peter Healy is shown as holding 72,673 subordinate voting shares of Trulieve Cannabis Corp. This figure reflects his direct ownership position as reported in the filing, including the impact of the 23,438 restricted stock units awarded on March 13, 2026.

What are the vesting conditions for Peter Healy’s Trulieve restricted stock units?

The 23,438 restricted stock units granted to Peter Healy will vest on the earliest of three events: the end of his service on Trulieve’s board of directors, a change of control of Trulieve, or December 1, 2032, according to the footnote disclosure.

Did Peter Healy buy Trulieve Cannabis Corp. shares on the open market?

No, Peter Healy did not buy shares on the open market. The Form 4 reports a grant of 23,438 restricted stock units at $0.00 per share, categorized as a grant, award, or other acquisition, which is typical equity compensation rather than a discretionary market purchase.

What type of security was reported in Peter Healy’s Trulieve Form 4 filing?

The filing reports subordinate voting shares of Trulieve Cannabis Corp., received through a grant of restricted stock units. Each RSU represents a contingent right to one subordinate voting share, with vesting tied to board service, change of control, or a December 1, 2032 vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/17/2026 - 04:41 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Healy Peter

(Last)

(First)

(Middle)

C/O TRULIEVE CANNABIS CORP.

3494 MARTIN HURST ROAD

(Street)

TALLAHASSEE

32312

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Trulieve Cannabis Corp. [ TRUL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Subordinate Voting Shares	03/13/2026		A		23,438⁽¹⁾	A	$0	72,673	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. The RSUs will vest on the earliest of (i) the end of the reporting person's service on the board of directors of Trulieve, (ii) a change of control of Trulieve, or (iii) December 1, 2032.

	/s/ Eric Powers, as Attorney-in-Fact	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR